SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 59 filers reported holding SUTRO BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $117,224 | -9.8% | 33,782 | +20.9% | 0.00% | – |
Q2 2023 | $129,893 | -14.5% | 27,934 | -15.0% | 0.00% | – |
Q1 2023 | $151,892 | -17.8% | 32,877 | +43.7% | 0.00% | – |
Q4 2022 | $184,830 | +88.6% | 22,875 | +29.2% | 0.00% | – |
Q3 2022 | $98,000 | -9.3% | 17,711 | -14.2% | 0.00% | – |
Q2 2022 | $108,000 | -44.6% | 20,654 | -13.2% | 0.00% | – |
Q1 2022 | $195,000 | -77.1% | 23,793 | -58.4% | 0.00% | – |
Q4 2021 | $850,000 | -19.3% | 57,150 | +2.5% | 0.00% | – |
Q3 2021 | $1,053,000 | +0.2% | 55,754 | -1.4% | 0.00% | -100.0% |
Q2 2021 | $1,051,000 | -60.5% | 56,554 | -51.6% | 0.00% | 0.0% |
Q1 2021 | $2,658,000 | +4.7% | 116,807 | -0.1% | 0.00% | -50.0% |
Q4 2020 | $2,538,000 | +1674.8% | 116,894 | +726.0% | 0.00% | – |
Q3 2020 | $143,000 | +123.4% | 14,152 | +72.1% | 0.00% | – |
Q2 2020 | $64,000 | +88.2% | 8,223 | +143.4% | 0.00% | – |
Q1 2020 | $34,000 | -58.5% | 3,379 | -55.3% | 0.00% | – |
Q4 2019 | $82,000 | +228.0% | 7,559 | +164.1% | 0.00% | – |
Q3 2019 | $25,000 | -75.0% | 2,862 | -67.9% | 0.00% | – |
Q2 2019 | $100,000 | -4.8% | 8,906 | -4.7% | 0.00% | – |
Q1 2019 | $105,000 | +20.7% | 9,349 | -4.7% | 0.00% | – |
Q4 2018 | $87,000 | – | 9,815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |